Analysis of Female Participant Representation in Registered Oncology Clinical Trials in the United States from 2008 to 2020

BACKGROUND: Female underrepresentation in oncology clinical trials can result in outcome disparities. We evaluated female participant representation in US oncology trials by intervention type, cancer site, and funding. MATERIALS AND METHODS: Data were extracted from the publicly available Aggregate...

Descripción completa

Detalles Bibliográficos
Autores principales: Perera, Nirosha D, Bellomo, Tiffany R, Schmidt, Walker M, Litt, Henry K, Shyu, Margaret, Stavins, MaKenna A, Wang, Max M, Bell, Alexander, Saleki, Massoud, Wolf, Katherine I, Ionescu, Ruxandra, Tao, Jacqueline J, Ji, Sunjong, O’Keefe, Ryan M, Pun, Matthew, Takasugi, Jordan M, Steinberg, Jecca R, Go, Ronald S, Turner, Brandon E, Mahipal, Amit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Health Outcomes and Economics of Cancer Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243778/
https://www.ncbi.nlm.nih.gov/pubmed/36848266
http://dx.doi.org/10.1093/oncolo/oyad009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243778/
https://www.ncbi.nlm.nih.gov/pubmed/36848266
http://dx.doi.org/10.1093/oncolo/oyad009

Ejemplares similares